Pharma firm Anges and Osaka University to begin testing coronavirus vaccine on animals

Published Tue, Mar 24, 2020 · 12:53 AM

[TOKYO] Japanese biopharmaceutical firm Anges Inc said on Tuesday it and partner Osaka University had completed development of a prophylactic DNA vaccine against the new coronavirus and that it would begin testing it in animals soon.

Shares of Anges were untraded with a glut of buy orders in early morning.

There are now more than 350,000 cases of coronavirus infections globally and over 15,000 deaths resulting from the disease it causes, called Covid-19.

REUTERS

Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.

Share with us your feedback on BT's products and services